INACTIVE
Full-Time
Vice President
Quality Assurance
Posted on 2/9/2024
Develops precision oncology therapies
Biotechnology
Compensation Overview
$265,000 - $350,000Annually
Expert
San Carlos, CA, USA
Required Skills
Google Cloud Platform
Requirements
- Advanced degree in a relevant technical discipline such as chemistry or pharmaceutics.
- Minimum 15 years of relevant experience in the pharmaceutical industry with at least 10 years management in GMP and/or GCP quality enabling end-to-end drug development and post launch.
- Proven track record of leadership and people management.
- Hands on experience in the development, establishment, management, and defense of Quality systems, both internally and externally.
- Experience with small molecule development, including pivotal trials, inspections, and commercialization.
- Strong knowledge of GCP, ICH, FDA, EMA, as well as other relevant US and international regulatory requirements.
- Strong interpersonal, teamwork, and organizational skills, as well as effective oral and written communication skills.
- Some travel required.
Responsibilities
- Develop and execute the long-term vision and strategy for RevMed quality.
- Be an advocate in senior management for quality representation, budgets, and visibility.
- Ensure all areas of quality are adequately resourced and appropriately focused.
- Establishing a patient focused Quality Culture and sustaining a program that engages all functions at RevMed to strive for a culture of quality internally and a reputation of excellence externally with our patients, investigators, and our regulators.
- Ensure effective quality infrastructure is in place for late development and global commercialization.
- Set policy and strategy for RevMed quality, including approach to outsourcing, and partnering (quality agreements).
- Grow, motivate, and develop staff at all levels.
- Foster a culture of continuous improvement in all aspects of quality, including the development and administration of policies and practices that address quality issues throughout the organization.
Revolution Medicines specializes in developing precision oncology therapies, particularly RAS(ON) inhibitors and RAS Companion inhibitors, with their lead product candidate, RMC-4630, currently in a Phase 1/2 clinical program targeting specific oncogenic mutations in various tumor types. The company's main focus is on developing these therapies to target specific oncogenic mutations in different tumor types, utilizing precision oncology technologies.
Company Stage
IPO
Total Funding
$1.3B
Headquarters
Redwood City, California
Founded
2014
Growth & Insights
Headcount
6 month growth
↑ 22%1 year growth
↑ 50%2 year growth
↑ 102%INACTIVE